Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neuropsychopharmacology
DOI: 10.1038/npp.2009.176
Authors: Herbert Y Meltzer, Roger Mills, Stephen Revell, Hilde Williams, Ann Johnson, Daun Bahr, Joseph H Friedman
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1967630951
